Simplex Trading, LLC Vaxart, Inc. Transaction History
Simplex Trading, LLC
- $175 Billion
- Q2 2025
A detailed history of Simplex Trading, LLC transactions in Vaxart, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 12,892 shares of VXRT stock, worth $4,125. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,892
Previous 20,887
38.28%
Holding current value
$4,125
Previous $8,000
37.5%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding VXRT
# of Institutions
82Shares Held
22.9MCall Options Held
66.1KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA10.4MShares$3.33 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.33MShares$744,4380.0% of portfolio
-
Black Rock Inc. New York, NY1.77MShares$567,7900.0% of portfolio
-
Marshall Wace, LLP London, X01.76MShares$564,4420.0% of portfolio
-
State Street Corp Boston, MA851KShares$272,3580.0% of portfolio
About Vaxart, Inc.
- Ticker VXRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,506,000
- Market Cap $40.5M
- Description
- Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...